ADVANCED PHARMACOLOGY FOR
u u u
PRESCRIBERS 1ST EDITION BY LUO K
u u u u u
AYINGO TEST BANK | 2024 UPDATE
u u u u u
, Table of Contents
u u
Chapteru 1:u AnuIntroductionu tou Evidence-Basedu Clinicalu Practiceu Guidelines .............................................. 3
Chapteru 2:uPharmacokineticsu /Chapter3:u Pharmacodynamics .................................................................... 13
Chapter4:u Pharmacogeneticsu anduPharmacogenomics ................................................................................ 25
Chapteru 5:uPharmacologyu Acrossu theuLifeuSpan ......................................................................................... 30
Chapteru 6:uDrug-TherapyuPrescribinguinuSpecialu Populations .................................................................... 36
Chapteru 7:u DruguDevelopmentu anduApproval ............................................................................................. 45
Chapteru 8-Chapteru 10:uFoundationsu ofu PrescriptionuWritingu Chapteru 9:u ResponsibleControlled-
SubstanceuPrescribinguChapteru10:uAntibioticuStewardship ........................................................................ 51
Chapteru 11:u ApplieduCalculationsu foru Prescribing ...................................................................................... 58
Chapteru 12-:uPromotingu AdherenceuWithuPharmacotherapyu II:u System-Specificu anduPatient-
FocuseduPrescribinguChapteru 13:u Pharmacotherapyuforu Ear,u Nose,u Mouth,u andThroatu Conditionsu/Chapteru
14:uPharmacotherapyuforuEyeuConditions .................................................................................................... 67
Chapteru 15:u Pharmacotherapyu foru Skinu Conditions .................................................................................... 74
Chapteru 16:uPharmacotherapyu foru Neurologicu Conditions .......................................................................... 81
Chapteru 17:u Pharmacotherapyu foru Cardiovascularu Conditions ................................................................... 94
Chapteru 18:u Pharmacotherapyu foru Respiratoryu Conditions ....................................................................... 106
Chapteru 19:u Pharmacotherapyu foru Gastrointestinalu Conditionsu andu Conditionsu RequiringNutritionaluSuppo
rt ................................................................................................................................................................ 117
Chapteru 20:uPharmacotherapyu foru Genitourinaryu Conditions ................................................................... 128
Chapteru 21:u Pharmacotherapyuforu Renal,u Acid–Base,u Fluid,u anduElectrolyteuDisorders .......................... 133
Chapteru 22:u Pharmacotherapyu foru Musculoskeletalu andu Rheumatologicu Conditions ............................... 146
Chapteru 23:uTherapeuticu Applicationsu ofu Immunologyu andu Vaccines ...................................................... 158
Chapteru 24:uPharmacotherapyu foru EndocrineuDisorders ........................................................................... 163
Chapteru 25:uPharmacotherapyu foru Hematologicu Disorders ....................................................................... 174
Chapteru 26:u Hematology/Oncologyu anduSupportiveu Careuforu theuNononcologist..................................... 190
Chapteru 27:uPharmacotherapyu Relatedu touWomen’su Healthu Conditions ................................................... 196
Chapteru 28:u Pharmacotherapyu Relatedu touMen’su Healthu Conditions ........................................................ 211
Chapteru 29:u Pharmacotherapyu Relatedu touTransgenderu Care .................................................................... 217
Chapteru 30:u AntimicrobialuPharmacotherapy............................................................................................ 224
Chapteru 31:uAntiretroviraluPharmacotherapy ............................................................................................ 235
Chapteru32:uPsychopharmacologyuanduIntegrativeuHealth:uCombineduTreatmentuofPsychiatricuanduNeuroco
gnitiveuConditions ..................................................................................................................................... 247
Chapteru 33:uPharmacotherapyu foru PainuManagement ............................................................................... 257
Chapteru 34:uSubstanceu UseuDisorderu III:u HealthuPromotionu anduMaintenance ......................................... 267
Chapteru 35:uOver-the-Counteru Medications .............................................................................................. 283
Chapteru 36:u Pharmacotherapyu foru Obesity ................................................................................................ 291
,Chapteru1:uAnuIntroductionu touEvidence-Basedu ClinicaluPracticeuGuidelines
MULTIPLEuCHOICE
• Whatuisutheuprimaryu purposeu ofutheu nursingu assessment?
A. Identifyingu underlyingu pathologicu conditions
B. Assistingu theu physicianu inuidentifyingu medicalu conditions
C. Determiningu theu patientsumentalustatus
D. Exploringu patientu responsesu tou healthu problems
ANS:uD
Aunursingu assessmentu isu doneu touidentifyutheu patientsu responseutouhealthupro
blems.uDuringu theunursingu assessmentu phase,uaucomprehensiveuinformationu
baseu isu developedu throughuau physicaluexamination,u nursinguhistory,u medicat
ionu history,u anduprofessionalu observation.u Identifyinguunderlyingu pathologic
u conditionsu andu assistingu theu physicianu inu identifyingumedicaluconditionsu isu
notupartuofutheu nursinguprocess.u Determiningu theupatientsu mentalustatusu isu on
eu partu ofutheu nursingu assessment,u butu itu isu notutheuprimaryupurpose.
DIF:u Cognitiveu Level:u Comprehensionu
REF:udmu 36uOBJ:u1u |u3uTOP:uNursinguP
rocessuStep:uAssessment
MSC:uNCLEXu Clientu Needsu Category:u HealthuPromotionu andu Maintenance
• Whatuisutheubasisu ofutheu NANDAuIu taxonomy?
A. Functionalu healthupatterns
B. Humanuresponseu patterns
C. Basicu humanu needs
D. Pathophysiologicu needs
ANS:uB
TheuNANDAuIutaxonomyu identifiesu humanu responseu patterns.uFunctiona
lucomponentsuofuhealthupatternsuareulimitedutouactivity,ufluiduvolume,unutriti
on,uselfucare,uandusensoryuperception.uBasicuhumanuneedsucompriseulessutha
numerelyuhealthupatterns.u Pathophysiologicuneedsu areunotupartuofutheuscop
euofuNANDAuI.
, DIF:uCognitiveu Level:u Knowledgeu
REF:upp.u37-38uOBJ:u5uTOP:
NursinguProcessuStep:uDiagnosis
MSC:uNCLEXu Clientu Needsu Category:u Physiologicalu Integrity
• Whichutasku isuincludedu inutheuassessmentu stepu ofutheu nursingu process?
A. Establishingu patientu goals/outcomes
B. Implementingu theu nursingu careu planu (NCP)
C. Measuringu goal/outcomeu achievement
D. Collectingu andu communicatingu data
ANS:uD
Datau areu collecteduanducommunicatedu inutheu assessmentu phaseu ofutheunursin
guprocess.u Establishingu goalsu isutheufunctionu ofu planning.
Implementingu theu NCPuisu theu functionu ofu implementation.u Measuringuoutco
meuachievementu isu theufunctionuofuevaluation.
DIF:u Cognitiveu Level:u Comprehensionu
REF:udmu 36uOBJ:u2u |u3uTOP:uNursinguP
rocessuStep:uAssessment
MSC:uNCLEXu Clientu Needsu Category:u HealthuPromotionu andu Maintenance
• Whichustatementu regardingu nursingu diagnosesu isu accurate?
a. Nursingu diagnosesu remainutheusameu foruasu longuasutheudiseaseu isu present.
b. Nursingu diagnosesu areu writtenu touidentifyudiseaseustates.
c. Nursingu diagnosesu describeu patientu problemsu thatu nursesu treat.
d. Nursingu diagnosesu identifyu causesu relatedu touillness.
ANS:uC
Diagnosticu statementsu identifyu problemsu au nurseu isu independentlyu ableu toutr
eatu withinu theu scopeu ofuprofessionalupractice.u Nursingu diagnosesu varyuwithut
heuchangingu conditionu ofutheu patient.uTheuresponseu patternsu areuuniqueutouth
eupatientuanduareunotu diseaseu specific.uNursingu diagnosesudescribeutheupatien
tsu humanuresponseupattern.
DIF:u Cognitiveu Level:u Comprehension
u u u
PRESCRIBERS 1ST EDITION BY LUO K
u u u u u
AYINGO TEST BANK | 2024 UPDATE
u u u u u
, Table of Contents
u u
Chapteru 1:u AnuIntroductionu tou Evidence-Basedu Clinicalu Practiceu Guidelines .............................................. 3
Chapteru 2:uPharmacokineticsu /Chapter3:u Pharmacodynamics .................................................................... 13
Chapter4:u Pharmacogeneticsu anduPharmacogenomics ................................................................................ 25
Chapteru 5:uPharmacologyu Acrossu theuLifeuSpan ......................................................................................... 30
Chapteru 6:uDrug-TherapyuPrescribinguinuSpecialu Populations .................................................................... 36
Chapteru 7:u DruguDevelopmentu anduApproval ............................................................................................. 45
Chapteru 8-Chapteru 10:uFoundationsu ofu PrescriptionuWritingu Chapteru 9:u ResponsibleControlled-
SubstanceuPrescribinguChapteru10:uAntibioticuStewardship ........................................................................ 51
Chapteru 11:u ApplieduCalculationsu foru Prescribing ...................................................................................... 58
Chapteru 12-:uPromotingu AdherenceuWithuPharmacotherapyu II:u System-Specificu anduPatient-
FocuseduPrescribinguChapteru 13:u Pharmacotherapyuforu Ear,u Nose,u Mouth,u andThroatu Conditionsu/Chapteru
14:uPharmacotherapyuforuEyeuConditions .................................................................................................... 67
Chapteru 15:u Pharmacotherapyu foru Skinu Conditions .................................................................................... 74
Chapteru 16:uPharmacotherapyu foru Neurologicu Conditions .......................................................................... 81
Chapteru 17:u Pharmacotherapyu foru Cardiovascularu Conditions ................................................................... 94
Chapteru 18:u Pharmacotherapyu foru Respiratoryu Conditions ....................................................................... 106
Chapteru 19:u Pharmacotherapyu foru Gastrointestinalu Conditionsu andu Conditionsu RequiringNutritionaluSuppo
rt ................................................................................................................................................................ 117
Chapteru 20:uPharmacotherapyu foru Genitourinaryu Conditions ................................................................... 128
Chapteru 21:u Pharmacotherapyuforu Renal,u Acid–Base,u Fluid,u anduElectrolyteuDisorders .......................... 133
Chapteru 22:u Pharmacotherapyu foru Musculoskeletalu andu Rheumatologicu Conditions ............................... 146
Chapteru 23:uTherapeuticu Applicationsu ofu Immunologyu andu Vaccines ...................................................... 158
Chapteru 24:uPharmacotherapyu foru EndocrineuDisorders ........................................................................... 163
Chapteru 25:uPharmacotherapyu foru Hematologicu Disorders ....................................................................... 174
Chapteru 26:u Hematology/Oncologyu anduSupportiveu Careuforu theuNononcologist..................................... 190
Chapteru 27:uPharmacotherapyu Relatedu touWomen’su Healthu Conditions ................................................... 196
Chapteru 28:u Pharmacotherapyu Relatedu touMen’su Healthu Conditions ........................................................ 211
Chapteru 29:u Pharmacotherapyu Relatedu touTransgenderu Care .................................................................... 217
Chapteru 30:u AntimicrobialuPharmacotherapy............................................................................................ 224
Chapteru 31:uAntiretroviraluPharmacotherapy ............................................................................................ 235
Chapteru32:uPsychopharmacologyuanduIntegrativeuHealth:uCombineduTreatmentuofPsychiatricuanduNeuroco
gnitiveuConditions ..................................................................................................................................... 247
Chapteru 33:uPharmacotherapyu foru PainuManagement ............................................................................... 257
Chapteru 34:uSubstanceu UseuDisorderu III:u HealthuPromotionu anduMaintenance ......................................... 267
Chapteru 35:uOver-the-Counteru Medications .............................................................................................. 283
Chapteru 36:u Pharmacotherapyu foru Obesity ................................................................................................ 291
,Chapteru1:uAnuIntroductionu touEvidence-Basedu ClinicaluPracticeuGuidelines
MULTIPLEuCHOICE
• Whatuisutheuprimaryu purposeu ofutheu nursingu assessment?
A. Identifyingu underlyingu pathologicu conditions
B. Assistingu theu physicianu inuidentifyingu medicalu conditions
C. Determiningu theu patientsumentalustatus
D. Exploringu patientu responsesu tou healthu problems
ANS:uD
Aunursingu assessmentu isu doneu touidentifyutheu patientsu responseutouhealthupro
blems.uDuringu theunursingu assessmentu phase,uaucomprehensiveuinformationu
baseu isu developedu throughuau physicaluexamination,u nursinguhistory,u medicat
ionu history,u anduprofessionalu observation.u Identifyinguunderlyingu pathologic
u conditionsu andu assistingu theu physicianu inu identifyingumedicaluconditionsu isu
notupartuofutheu nursinguprocess.u Determiningu theupatientsu mentalustatusu isu on
eu partu ofutheu nursingu assessment,u butu itu isu notutheuprimaryupurpose.
DIF:u Cognitiveu Level:u Comprehensionu
REF:udmu 36uOBJ:u1u |u3uTOP:uNursinguP
rocessuStep:uAssessment
MSC:uNCLEXu Clientu Needsu Category:u HealthuPromotionu andu Maintenance
• Whatuisutheubasisu ofutheu NANDAuIu taxonomy?
A. Functionalu healthupatterns
B. Humanuresponseu patterns
C. Basicu humanu needs
D. Pathophysiologicu needs
ANS:uB
TheuNANDAuIutaxonomyu identifiesu humanu responseu patterns.uFunctiona
lucomponentsuofuhealthupatternsuareulimitedutouactivity,ufluiduvolume,unutriti
on,uselfucare,uandusensoryuperception.uBasicuhumanuneedsucompriseulessutha
numerelyuhealthupatterns.u Pathophysiologicuneedsu areunotupartuofutheuscop
euofuNANDAuI.
, DIF:uCognitiveu Level:u Knowledgeu
REF:upp.u37-38uOBJ:u5uTOP:
NursinguProcessuStep:uDiagnosis
MSC:uNCLEXu Clientu Needsu Category:u Physiologicalu Integrity
• Whichutasku isuincludedu inutheuassessmentu stepu ofutheu nursingu process?
A. Establishingu patientu goals/outcomes
B. Implementingu theu nursingu careu planu (NCP)
C. Measuringu goal/outcomeu achievement
D. Collectingu andu communicatingu data
ANS:uD
Datau areu collecteduanducommunicatedu inutheu assessmentu phaseu ofutheunursin
guprocess.u Establishingu goalsu isutheufunctionu ofu planning.
Implementingu theu NCPuisu theu functionu ofu implementation.u Measuringuoutco
meuachievementu isu theufunctionuofuevaluation.
DIF:u Cognitiveu Level:u Comprehensionu
REF:udmu 36uOBJ:u2u |u3uTOP:uNursinguP
rocessuStep:uAssessment
MSC:uNCLEXu Clientu Needsu Category:u HealthuPromotionu andu Maintenance
• Whichustatementu regardingu nursingu diagnosesu isu accurate?
a. Nursingu diagnosesu remainutheusameu foruasu longuasutheudiseaseu isu present.
b. Nursingu diagnosesu areu writtenu touidentifyudiseaseustates.
c. Nursingu diagnosesu describeu patientu problemsu thatu nursesu treat.
d. Nursingu diagnosesu identifyu causesu relatedu touillness.
ANS:uC
Diagnosticu statementsu identifyu problemsu au nurseu isu independentlyu ableu toutr
eatu withinu theu scopeu ofuprofessionalupractice.u Nursingu diagnosesu varyuwithut
heuchangingu conditionu ofutheu patient.uTheuresponseu patternsu areuuniqueutouth
eupatientuanduareunotu diseaseu specific.uNursingu diagnosesudescribeutheupatien
tsu humanuresponseupattern.
DIF:u Cognitiveu Level:u Comprehension
